title: Should all breast cancer patients with symptomatic bone metastasis be treated with bisphosphonates? The case against.
authors.affiliation: Mount Vernon Cancer Centre, Northwood, Middlesex, UK. peterhoskin@nhs.net
authors.forename: P J
authors.initials: PJ
authors.lastname: Hoskin
mesh_terms: D001859:Bone Neoplasms / Q000188:drug therapy* / Q000517:prevention & control / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology*; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010347:Patient Care Planning
chemical_list: D004164:Diphosphonates